RS-3000 Advance Clinical Library Courtesy Of Kittner Eye Center UNC
|
|
|
- Rafe Casey
- 5 years ago
- Views:
Transcription
1 RS-3000 Advance Clinical Library Courtesy Of Kittner Eye Center UNC
2 Info We would like to first thank our friends at Kittner Eye Center at UNC for providing us with these amazing images taken on the NIDEK RS-3000 Advance OCT. This book showcases images taken from the RS-3000 Advance of different eye pathology and ailments. Keith Effert / Product Development Marketing Manager usa.nidek.com / keith_effert@nidek.com 3
3 PIC Punctate Inner Choroidopathy 4 5 J. Niklas Ulrich, MD - Assistant Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
4 DME Diabete Macular Edema 6 7 Odette M. Houghton, MD Associate Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
5 Macular Pucker 8 9 Odette M. Houghton, MD Associate Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
6 DME Diabetic Macular Edema Odette M. Houghton, MD Associate Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
7 ARMD Age-Related Macular Degeneration Maurice B. Landers, Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
8 Coats Disease J. Niklas, Ulrich, MD Assistant Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
9 CRVO J. Niklas, Ulrich, MD Assistant Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
10 Diabetic Retinopathy Maurice B. Landers, MD Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
11 CSDME Clinically Significant Diabetic Macular Edema Maurice B. Landers, MD Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
12 IPCV Idiopathic Polypoidal Choroidal Vasculopathy J. Niklas Ulrich, MD Assistant Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
13 BRVO Odette M. Houghton, MD Assistant Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
14 Retinal Edema Seema Garg, MD, PhD Associate Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
15 Autoimmune Retinopathy Seema Garg, MD, PhD Associate Professor & Debra Cantrell, COA - Ophthalmic Imaging Specialist
16 IPCV Idiopathic Polypoidal Choroidal Vasculopathy J. Niklas Ulrich, MD Assistant Professor & Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
17 Stargardts Odette M. Houghton, MD Assistant Professor -- Houston Powell Sharpe III, COA, OCT-C, Ophthalmic Imaging Specialist
18 Retinal Detachment Macula Off J. Niklas Ulrich, MD Assistant Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
19 DME Diabetic Macular Edema Odette M. Houghton, MD Associate Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
20 Radiation Retinopathy Odette M. Houghton, MD Associate Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
21 Optic Nerve Pit Maurice B. Landers, MD Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
22 Myopic Degeneration Odette M. Houghton, MD Associate Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
23 BRVO J. Niklas Ulrich, MD Assistant Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
24 Exudative AMD J. Niklas Ulrich, MD Assistant Professor Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist
25 Loculated Subretinal Fluid Following Repir of Chronic Retinal Detachment Odette M. Houghton, MD Associate Professor Rona Lyn Esquejo-Leon, CRA
26 Exudative AMD J. Niklas Ulrich, MD Assistant Professor Rona Lyn Esquejo-Leon, CRA
27 Retinal Vascular Anomaly Odette M. Houghton, MD Associate Professor Sarah Moyer, CRA, OCT-C, FOPS
28 Epiretinal Membrane Odette M. Houghton, MD Associate Professor Sarah Moyer, CRA, OCT-C, FOPS
29 Exudative AMD J. Niklas Ulrich, MD Assistant Professor Sarah Moyer, CRA, OCT-C, FOPS
30 Special Thanks to: Kittner Eye Center Images Diagnosed By: J. Niklas Ulrich, MD Assistant Professor Seema Garg, MD, PhD Odette M. Houghton, MD Maurice B. Landers, MD Associate Professor Associate Professor Professor Images Acquired By: Sarah Moyer, CRA, OCT-C, FOPS Rona Lyn Esquejo-Leon, CRA Manager, Ophthalmic Imaging Ophthalmic Imaging Specialist Houston Powell Sharpe III, COA, OCT-C Ophthalmic Imaging Specialist Debra Cantrell, COA Ophthalmic Imaging Specialist Caution: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of physician or other licensed eye care practitioner. Specifications and design are subject to change without notice. Specification may vary depending on circumstances in each country
Overview. Macular OCT Artifact Study
Imaging Artifacts Sarah Moyer, CRA, OCT-C Director, Ophthalmic Imaging Kittner Eye Center University of North Carolina Chapel Hill, NC Disclose financial interest now Overview Sarah s Thoughts on Artifacts
Learn Connect Succeed. JCAHPO Regional Meetings 2017
Learn Connect Succeed JCAHPO Regional Meetings 2017 How Retinal Imaging Guides Treatment Odette Margit Houghton MD Question 1 Which OCT has the highest resolution? A: Swept source OCT B: Spectral domain
UNC EYE SYMPOSIUM. Course Director, Donald L. Budenz, MD, MPH APRIL Hosted by. Sponsored by
APRIL 11 2015 Hosted by UNC DEPARTMENT OF OPHTHALMOLOGY THE KITTNER EYE CENTER Sponsored by UNC SCHOOL OF MEDICINE UNC EYE Course Director, Donald L. Budenz, MD, MPH Registration Information The UNC is
Experience Spectacular Retinal Imaging with the new NIDEK F-10 Digital Ophthalmoscope
Experience Spectacular Retinal Imaging with the new NIDEK F-10 Digital Ophthalmoscope The F-10 was developed to give Ophthalmologists a high definition (HD) diagnostic imaging system. Designed to provide
Posterior Segment Update
Posterior Segment Update Featured Speaker: Dr. Kyle Cheatham, FAAO, DIP ABO DISCLOSURE STATEMENT We have no direct financial or proprietary interest in any companies, products or services mentioned in
Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP
Optical Coherence Tomography in Diabetic Retinopathy Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP Content OCT imaging Retinal layers OCT features in Diabetes Some NON DR features
Swept-Source Optical Coherence Tomography
Swept-Source Optical Coherence Tomography A Color Atlas This page intentionally left blank Swept-Source Optical Coherence Tomography A Color Atlas Kelvin Y.C. Teo Wong Chee Wai Andrew S.H. Tsai Daniel
Bayer s Commitment in Ophthalmology. Zig Lang, MD, PhD Vice President and Head of Medical Affairs & Pharmacovigilance, Bayer HealthCare Company Ltd.
Bayer s Commitment in Ophthalmology Zig Lang, MD, PhD Vice President and Head of Medical Affairs & Pharmacovigilance, Bayer HealthCare Company Ltd. Bayer s commitment to addressing unmet needs in ophthalmology
Rising to the Challenge of Satisfying Unmet Medical Needs. Back-of-the-eye. Main Back-of-the-Eye Diseases. Uveitis. Behcet s disease.
Feature Rising to the Challenge of Satisfying Unmet Medical Needs Eyeing Further Specialization Back-of-the-eye Diseases Main Back-of-the-Eye Diseases Age-related macular degeneration Uveitis Behcet s
Ophthalmic VEGF Inhibitors. Eylea (aflibercept), Macugen (pegaptanib) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Ophthalmic VEGF Inhibitors Page: 1 of 5 Last Review Date: September 20, 2018 Ophthalmic VEGF Inhibitors
Ophthalmologic Policy. Vascular Endothelial Growth Factor (VEGF) Inhibitors
Ophthalmologic Policy UnitedHealthcare Commercial Drug Policy Vascular Endothelial Growth Factor (VEGF) Inhibitors Policy Number: 2016D0042H Effective Date: October 1, 2016 Table of Contents Page INSTRUCTIONS
OCT Angiography in Primary Eye Care
OCT Angiography in Primary Eye Care An Image Interpretation Primer Julie Rodman, OD, MS, FAAO and Nadia Waheed, MD, MPH Table of Contents Diabetic Retinopathy 3-6 Choroidal Neovascularization 7-9 Central
EYLEA. (aflibercept solution for injection) Patient Guide
EYLEA (aflibercept solution for injection) Patient Guide Eylea is used to treat Wet Age-Related Macular Degeneration (Wet AMD), macular oedema secondary to Branch and Central Retinal Vein Occlusion (BRVO
The College of Optometrists - Learning outcomes for the Professional Certificate in Medical Retina
Learning outcomes for the Professional Certificate in Medical Retina, incorporating diabetic retinopathy screening and age related macular degeneration The professional certificate is a prerequisite to
Advanced Vitreoretinal Techniques & Technology Symposium
14th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium JULY 25-27, 2014 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT STATEMENT This activity has been planned and implemented
Ophthalmic Imager Role
MASTER OCT Ophthalmic Photographers Society October 18, 2014 Chicago, IL James B Soque, CRA COA Pamela A Weber, MD Island Retina Shirley, New York Commack, New York Financial Disclosure Genentech Ophthotech
FA vs. OCTA? The status of OCTA, today. Fukuoka, JSOS 2016 Gerd Klose. Korobelnik J Fr Ophthalmol (2015)
FA vs. OCTA? The status of OCTA, today Korobelnik J Fr Ophthalmol (2015) Fukuoka, JSOS 2016 Gerd Klose 1 2 FA / ICGA a well-founded Gold standard! Benefits Useful for many pathologies High contrast, detailed
INTRAVITREAL IMPLANTS
INTRAVITREAL IMPLANTS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs
There are no published randomized, double-blind trials comparing aflibercept to other therapies in neovascular AMD.
Subject: Eylea (aflibercept) Original Effective Date: 7/11/2014 Policy Number: MCP-191 Revision Date(s): 10/11/2016 Review Date(s): 12/16/2015; 10/11/2016, 6/22/2017, 7/10/2018 DISCLAIMER This Medical
Contents. Chapter 1 Common Pitfalls in the Use of Optical Coherence Tomography for Macular Diseases Lihteh Wu and Teodoro Evans
Contents Chapter 1 Common Pitfalls in the Use of Optical Coherence Tomography for Macular Diseases Lihteh Wu and Teodoro Evans 1.1 Introduction... 1 1.2 Limitations of Time-Domain OCT... 2 1.2.1 Acquisition
Patient AB. Born in 1961 PED
Clinical Atlas Patient AB Born in 1961 PED Autofluorescence Dilated 45 EasyScan Zero-dilation IR 45 Fundus Dilated 45 In the fundus photos (Canon CX1) the PED is not able to be seen. However, the extent
Oishi A, Miyamoto K, Yoshimura N. Etiology of carotid cavernous fistula in Japanese. Jpn J Ophthalmol. 2009;53:40-43.
Kimura T, Takagi H, Miyamoto K, Kita M, Watanabe D, Yoshimura N. Macular hole with epiretinal membrane after triamcinolone-assisted vitrectomy for proliferative diabetic retinopathy. Retinal Cases Brief
Authors. Introduction. Introduction. Materials and Methods. Objective 10/27/2015
Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) in Thai Population Presenting with Choroidal Neovascularization (CNV) A multicenter study Authors Yonrawee Piyacomn 1, Chavakij Bhoomibunchoo 1, Yosanan
Telemedicine Diagnostic Challenges for Diabetic Retinopathy
Telemedicine Diagnostic Challenges for Diabetic Retinopathy Ingrid Zimmer-Galler, M.D. Johns Hopkins Office of Telemedicine Financial Disclosures None 1 Telemedicine Diabetic Retinopathy Screening Performed
2015 Ophthalmic Imaging INVITED GUESTS
2015 Ophthalmic Imaging Saturday, September 26, 2015 Northwestern Memorial Hospital Feinberg Pavilion - Pritzker Auditorium, Chicago, IL Attendees are eligible for 6.75 AMA PRA Category 1 Credits TM INVITED
Prevalence and causes of macular edema and its correlation: an observational study
Original Article Prevalence and causes of macular edema and its correlation: an observational study Ishtpreet Mann, Rajwinder Kaur, Balbir Khan, Prithpal S Matreja *, R N Bhatnagar Undergraduate, Gian
Royal Berkshire Hospital Dunedin Hospital. Prince Charles Eye Unit Pi Princess Margaret Hospital
Vitreoretinal Surgery Mr Vaughan Tanner www.tanner-eyes.co.uk eyes Reading Royal Berkshire Hospital Dunedin Hospital Windsor Prince Charles Eye Unit Pi Princess Margaret Hospital Success rates VR surgery
OCT Angiography The Next Frontier
Choroid Retina avascular 5/13/2017 OCT Angiography The Next Frontier Pierce Kenworthy OD, FAAO June 9, 2017 OCT Angiography (OCTA) 2016 Non-invasive, motion contrast imaging Represents erythrocyte movement
OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS
UnitedHealthcare Commercial Medical Benefit Drug Policy OPHTHALMOLOGIC POLICY: VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITORS Policy Number: PHA020 Effective Date: September 1, 2018 Table of Contents
Bayer to showcase latest Ophthalmology research at EURETINA 2017
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com 17 th European Society of Retina Specialists (EURETINA) Congress Bayer to showcase
The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis
OPTICAL COHERENCE TOMOGRAPHY The Quick Guide to OCT Mastery 50 Real Cases with Expert Analysis VOL 1 Sanjay Sharma, MD, FRCS, MSc (Epid), MBA Ophthalmologist, Epidemiologist Queen s University, Canada
Date approved: 04/18/18. Approved by: Pharmacy and Therapeutics Quality Management Subcommittee Effective Date: Department of Origin: Pharmacy
Integrated Healthcare Services and Criteria Document: Reference #: PC/V001 Page: 1 of 9 PRODUCT APPLICATION: PreferredOne Administrative Services, Inc. (PAS) ERISA PreferredOne Administrative Services,
Course # Getting to Know Your OCT
Course # 140 Getting to Know Your OCT Course Title: Lecturer: Getting to Know Your OCT Brad Sutton, OD, FAAO IU School of Optometry Financial Disclosures No financial disclosures Optical Coherence Tomography-OCT
Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist
Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist PRESENT PROFESSIONAL POSITION OPHTALMOLOGIST DOCTOR, Private practice Retinal medical Specialist, DMLA in particular Installation year
Note: This is an outcome measure and can be calculated solely using registry data.
Measure #191 (NQF 0565): Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery -- National Quality Strategy Domain: Effective Clinical Care DESCRIPTION: Percentage of patients
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Cataract November 2016 Association of Health Professions in Ophthalmology General basic competences
OPTIC DISC PIT Pathogenesis and Management OPTIC DISC PIT
OPTIC DISC PIT Pathogenesis and Management Abdel-Latif Siam Ain Shams University Cairo Egypt OPTIC DISC PIT Congenital pit is an atypical coloboma usually located on the temporal edge of the disc, associated
Macular disorders: study of demographic patterns and management trends
Original Research Article Macular disorders: study of demographic patterns and management trends Preeti A. Patil 1, Surendra P. Wadgaonkar 2,*, Bhimrao S. Kamble 3, Rachana R. Tiwari 4 1 Assistant Professor,
Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
Columbia International Publishing Journal of Ophthalmic Research (2014) Research Article Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)
and at the same patient encounter. Code has been deleted. For scanning computerized ophthalmic diagnostic imaging of optic nerve and retin
92227: Remote imaging for detection of retinal disease (eg, retinopathy in a patient with diabetes) with analysis and report under physician supervision, unilateral or bilateral. For Medicare, bill only
NO FINANCIAL INTERESTS ARE DISCLOSED BY THE AUTHORS
OCULAR FINDINGS IN APLASTIC ANEMIA: MULTICENTER STUDY & LITERATURE REVIEW Ahmad M Mansour1, MD, Jong Wook Lee, MD, PhD, Seung Ah Yahng, MD, Kyu Seop Kim, MD, Maha Shahin, MD, Nelson Hamerschlak, MD, PhD,
Intraocular Radiation Therapy for Age-Related Macular Degeneration
Medical Policy Manual Medicine, Policy No. 134 Intraocular Radiation Therapy for Age-Related Macular Degeneration Next Review: April 2019 Last Review: June 2018 Effective: August 1, 2018 IMPORTANT REMINDER
2018 MIPS Quality Category Measures and Benchmarks for Ophthalmology
2018 MIPS Quality Category Measures and Benchmarks for Ophthalmology Physicians must report on 60% of all patients, if reporting via registry or EHR, and 60% of all Medicare Part B patients if reporting
Optical Coherence Tomography (OCT) in Uveitis Piergiorgio Neri, BMedSc, MD, PhD Head Ocular Immunology Unit
The Eye Clinic Polytechnic University of Marche Head: Prof Alfonso Giovannini November, 1991 Optical Coherence Tomography (OCT) in Uveitis Piergiorgio Neri, BMedSc, MD, PhD Head Ocular Immunology Unit
Brampton Hurontario Street Brampton, ON L6Y 0P6
Diabetic Retinopathy What is Diabetic Retinopathy Diabetic retinopathy is one of the leading causes of blindness world-wide. Diabetes damages blood vessels in many organs of the body including the eyes.
World Sight Day Case Studies. Mark Frost Screening Manager South East London DESP
World Sight Day 2015 Case Studies Mark Frost Screening Manager South East London DESP Introduction All of the following cases have been identified in our screening programme over the last 3 years. The
Age-Related Macular Degeneration
Age-Related Macular Degeneration Age-Related Macular Degeneration Age-related macular degeneration (AMD) is one of the most common causes of poor vision after age 60. AMD is a deterioration or breakdown
Will OCT-Angiography replace FA?
ASL Roma A PRESIDIO TERRITORIALE NUOVO REGINA MARGHERITA AMBULATORIO PATOLOGIE RETINICHE Resp. Dott.ssa SUSANNA CATALANO CENTRO ITALIANO MACULA Will OCT-Angiography replace FA? Marco Rispoli, Luca di Antonio,
Do You See What I See!!! Shane R. Kannarr, OD
Do You See What I See!!! Shane R. Kannarr, OD skannarr@kannarreyecare.com Define Specialty Testing Additional Test to: Prove/Disprove Diagnosis To monitor progression of a condition To document a condition
Amber Priority. Image Library
Amber Priority Image Library Amber flag Diabetic Maculopathy (M1) Pre-proliferative Diabetic Retinopathy (R2) Old, treated and now inactive DR (R1/M0/P1or R0/M0/P1) Where only partial or incomplete images
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Lucentis) Reference Number: CP.PHAR.186 Effective Date: 03.16 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Coding Implications Revision Log See Important Reminder at
The Foundation WHAT IS THE RETINA? continued next page. RETINA HEALTH SERIES Facts from the ASRS
The Foundation American Society of Retina Specialists Committed to improving the quality of life of all people with retinal disease. Epiretinal Membranes (ERMs), also commonly known as cellophane maculopathy
OCT Interpretation. Financial Disclosure. Jay M. Haynie, OD, FAAO. OCT Image Layers 7/21/2014
OCT Interpretation Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Olympia Tacoma Renton Kennewick - Washington Carl Zeiss
2017 MIPS Quality Category Measures and Benchmarks for Ophthalmology
2017 MIPS Quality Category Measures and Benchmarks for Ophthalmology Physicians must report on 50% of all patients, if reporting via registry or EHR, and 50% of all Medicare Part B patients if reporting
The Trust does not record electronically the number of patients who are treated by laser for a condition.
Ref: FOI/CAD/ID 3224 06 April 20 Please reply to: FOI Administrator Trust Management Maidstone Hospital Hermitage Lane Maidstone Kent ME 9QQ Email: mtw-tr.foiadmin@nhs.net Freedom of Information Act 2000
From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014
From Outdated to Updated: A Review of Important Clinical Trials in Ocular Disease from 2014 1. This course is designed to review the important ophthalmic literature that was released between October 2013
Vanderbilt Eye Institute Clinical Trials
April, 2010 Vanderbilt Eye Institute Clinical Trials Ophthalmology Actively Recruiting Studies For information on our clinical trials and other studies, please contact: Sandy Owings, COA, CCRP Clinic Director
Treatment of visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO):
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Treatment of visual impairment due to macular edema secondary to branch retinal
ZEISS AngioPlex OCT Angiography Overview ZEISS OCT Angiography
ZEISS AngioPlex OCT Angiography Overview ZEISS OCT Angiography California, ZEISS AngioPlex Ultra-clear visualization of microvascular blood flow using non-invasive OCT angiography 2 AngioPlex OCT Angiography
Since /01/2014 Private practice Ophthalmology, Retinal Medical Specialty and AMD, private office
Corinne GONZALEZ Ophthalmology (MD, Ph.D ) Retinal Medical Specialist SELARL CABINET DOCTEUR GONZALEZ 27, Boulevard des Minimes 31 200 Toulouse! 05 34 40 77 30 e-mail : cabinet.dr.gonzalez@wanadoo.fr Fax
Retinal Complications of Obstructive Sleep Apnea A Growing Concern!
Retinal Complications of Obstructive Sleep Apnea A Growing Concern! Jay M. Haynie, OD, FAAO Financial Disclosure I have received honoraria or am on the advisory board for the following companies: Carl
CENTENE PHARMACY AND THERAPEUTICS NEW DRUG REVIEW 2Q17 April May
BRAND NAME Lucentis GENERIC NAME ranibizumab MANUFACTURER Genentech, Inc. DATE OF APPROVAL June 30, 2006 PRODUCT LAUNCH DATE July 13, 2006 REVIEW TYPE Review type 1 (RT1): New Drug Review Full review of
Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema
Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema Ayman M Khattab MD, FRCS Professor of Ophthalmology Cairo University Diabetic Macular Edema (DME) Diabetic macular
Patient & Family Guide. Diabetes and the Eye. Aussi disponible en français : Le diabète et les yeux (FF )
Patient & Family Guide Diabetes and the Eye 2017 Aussi disponible en français : Le diabète et les yeux (FF85-1784) www.nshealth.ca Diabetes and the Eye What is diabetes? Diabetes is a disease in which
11/29/2016 MACULAR MALADIES: TYPICAL & ATYPICAL CASES
MACULAR MALADIES: TYPICAL & ATYPICAL CASES Dawn Pewitt, OD, FAAO Triad Eye Institute, Grove, OK Dpewitt@triadeye.com Disclosure Statement: No financial disclosures COPE 51218-PS Please silence all mobile
Learn Connect Succeed. JCAHPO Regional Meetings 2017
Learn Connect Succeed JCAHPO Regional Meetings 2017 Clinical Applications of Anterior Segment OCT Sarah Armstrong, CRA, OCT-C, FOPS Manager of Ophthalmic Imaging Kenneth L. Cohen, MD Sterling A. Barrett
3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives
Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University The author has no proprietary interest Today s Objectives Identify the CLINICAL SCENARIOS IN MACULAR EDEMA where OCT plays a MAJOR
Principle of OCT. Reading Between the Lines: OCT Interpretation. Initial Concept. Advantage: High Resolution Cross Section Images
Principle of OCT Reading Between the Lines: OCT Interpretation Mohammad Rafieetary, OD, FAAO mrafieetary@charlesretina.com Introduction Optical Biopsy Morphologic Evaluation of Live Tissue Measurements
Evaluation of efficacy of eplerenone in the management of chronic central serous choroidoretinopathy
Original article: Evaluation of efficacy of eplerenone in the management of chronic central serous choroidoretinopathy Dr. Sushant Madaan* Department of Ophthalmology, NIMS Medical College and Hopsital,Jaipur,
2016 PQRS Recommended Measures for: Ophthalmology
Measures Groups Choose 1 Measures Group Report on a minimum of 20 eligible patients (at least 11 must be Medicare Part B FFS patients) #130: Documentation of Current Medications in the Medical Record #226:
DIABETIC RETINOPATHY
THE UK GUIDE DIABETIC RETINOPATHY Everything you need to know about diabetic retinopathy Jaheed Khan BSc (Hons) MBBS MD FRCOphth Fellow of the Royal College of Ophthalmologists Association for Research
Heidelberg Spectralis
Clinical Applications of Anterior Segment OCT Sarah Moyer, CRA, OCT-C Director of Ophthalmic Imaging Kenneth L. Cohen, MD Professor of Ophthalmology Kittner Eye Center Department of Ophthalmology University
OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital
Progress Report for1 st Quarter, May-July 2017 OCT Image Analysis System for Grading and Diagnosis of Retinal Diseases and its Integration in i-hospital Milestone 1: Designing Annotation tool extraction
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Acute & Emergency Care November 2016 Association of Health Professions in Ophthalmology General
Choroidal Mapping; a Novel Approach for Evaluating Choroidal Thickness and Volume
Imaging Technique Choroidal Mapping; a Novel Approach for Evaluating Choroidal Thickness and Volume Jila Noori 1, MD; Mohammad Riazi Esfahani 1,2, MD Fedra Hajizadeh 2, MD; Mohammad-Mehdi Zaferani 1, MD
Editors Frank G.Holz Richard F. Spaide. Medical Retina. With 91 Figures, Mostly in Colour and13tables. Springer
Editors Frank G.Holz Richard F. Spaide Medical Retina With 91 Figures, Mostly in Colour and13tables Springer ääm mm.m iiiii HHHHHMmi Chapter1 Microperimetry in Macular Disease Klaus Rohrschneider 1.1 Introduction
Advanced Vitreoretinal Techniques & Technology Symposium
15th ANNUAL Advanced Vitreoretinal Techniques & Technology Symposium AUGUST 28-30, 2015 SWISSÔTEL CHICAGO CHICAGO, IL CME ACCREDITATION AND CREDIT DESIGNATION This activity has been planned and implemented
Updates to the Alberta Drug Benefit List. Effective August 1, 2017
Updates to the Alberta Drug Benefit List Effective August 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370
Clinically Significant Macular Edema (CSME)
Clinically Significant Macular Edema (CSME) 1 Clinically Significant Macular Edema (CSME) Sadrina T. Shaw OMT I Student July 26, 2014 Advisor: Dr. Uwaydat Clinically Significant Macular Edema (CSME) 2
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Glaucoma November 2016 Association of Health Professions in Ophthalmology General basic competences
Central venous occlusion
Central venous occlusion Central venous occlusion (right eye) There are dark haemorrhages at the macula and all over the retina. Choroidal haemangioma A choroidal haemangioma has salmon pink colour. There
What Is O.C.T. and Why Should I Give A Rip? OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist 5/19/2014
OCT & Me How Optical Coherence Tomography Changed the Life of a Small Town Optometrist Email: myoder@wcoil.com Mark A. Yoder, O.D. 107 N. Main Street PO Box 123 Bluffton, OH 45817 @yoderod 115.02 Histoplasma
FDA approves Roche s Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema
Media Release Basel, 9 February 2015 FDA approves Roche s Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema First eye medicine approved for treatment
Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD
Ganglion cell analysis by optical coherence tomography (OCT) Jonathan A. Micieli, MD Valérie Biousse, MD Figure 1. Normal OCT of the macula (cross section through the line indicated on the fundus photo)
Financial Disclosures
Financial Disclosures DB is a scientific advisor for Regeneron/ Bayer and Genentech/ Roche & a DB member of the Regeneron Combination Products Steering Committee RCH receives grant support from Regeneron/
MD Research News Issue November 2018
MD Research News Issue 399 2 November 2018 This free weekly bulletin lists the latest published research articles on macular degeneration (MD) and some other macular diseases as indexed in the NCBI, PubMed
*Pleasesee amendment forpennsylvaniamedicaid at the endofthis CPB.
1 of 134 Number: 0701 Policy *Pleasesee amendment forpennsylvaniamedicaid at the endofthis CPB. Aetna considers pegaptanib sodium injection (Macugen) medically necessary for the treatment of individuals
Splitting of Differentials: a New Type of Foveal Retinoschisis
Splitting of Differentials: a New Type of Foveal Retinoschisis Tobin Ansel, OD, MS Belinda Weinberg, OD Nancy Shenouda-Awad, OD, FAAO Abstract West Haven VA Medical Center Stellate Nonhereditary Idiopathic
Angio-OCT. Degenerazione Maculare Legata all Eta. Giuseppe Querques
Angio-OCT Degenerazione Maculare Legata all Eta Giuseppe Querques Department of Ophthalmology, IRCCS Ospedale San Raffaele, University Vita Salute San Raffaele, Milan, Italy Financial Disclosure ADVISORY
! Honoraria. " Kemin " Nicox " Review of Optometry " Optometric Management " VSP. ! Scientific Advisory Boards
Financial Disclosure: JP Choroid Chronicles Joseph J. Pizzimenti, OD, FAAO pizzimen@nova.edu! Honoraria " Kemin " Nicox " Review of Optometry " Optometric Management " VSP! Scientific Advisory Boards "
Coding Implications Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Eylea) Reference Number: CP.PHAR.184 Effective Date: 03.16 Last Review Date: 02.18 Line of Business: Commercial, Medicaid Coding Implications Revision Log See Important Reminder at the
f.a.q s Q. Why should I have an iwellness exam?
f.a.q s The iwellness exam is a quick and non-invasive scan of your eye that lets your doctor see the layers of your retina to aid in the diagnosis of sight-threatening eye disease. Q. Why should I have
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care
The Common Clinical Competency Framework for Non-medical Ophthalmic Healthcare Professionals in Secondary Care Medical Retina November 2016 Association of Health Professions in Ophthalmology General basic
International Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article A Multivariate Analysis of Intravitreal Injection of Anti-VEGF Bevacizumab in the Treatment
Diagnosis in AMD. Managing your AMD Patients
Managing your AMD Patients Robert W. Dunphy, O.D., F.A.A.O. Diagnosis in AMD Have suspicion Identify relative risk Conduct surveillance Biometry Utilize technology to facilitate detection of change / stability
Applying structure-function to solve clinical cases
Applying structure-function to solve clinical cases Professor Michael Kalloniatis Centre for Eye Health, and, School of Optometry and Vision Science Acknowledgements Some material prepared by Nayuta Yoshioka
2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process
Quality ID #14 (NQF 0087): Age-Related Macular Degeneration (AMD): Dilated Macular Examination National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY
PRODUCT MONOGRAPH. Pr EYLEA. Aflibercept. Single Use Vials for the Treatment of a Single Eye. 40 mg/ml Solution for Intravitreal Injection
PRODUCT MONOGRAPH Pr Aflibercept Single Use Vials for the Treatment of a Single Eye 40 mg/ml Solution for Intravitreal Injection Ophthalmological / Antineovascularization agent ATC Code: S01LA05 Manufactured
Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy
Peng et al. BMC Ophthalmology (2017) 17:87 DOI 10.1186/s12886-017-0481-8 RESEARCH ARTICLE Open Access Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary
Your eyes are. a window to your health. Take a closer look with optomap.
Your eyes are a window to your health. Take a closer look with optomap. Protect your vision. Bringing the most advanced technology to our patients, we recommend optomap ultra-wide digital retinal imaging